CORT Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 116527 min ago

@ $23.28

Wydano: 14 vas. 2024 @ 16:30

Zwrot: 5.33%

Poprzedni sygnał: vas. 13 - 16:30

Poprzedni sygnał: Kupno

Zwrot: 0.28 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States...

Stats
Dzisiejszy wolumen	1.68M
Średni wolumen	1.10M
Kapitalizacja rynkowa	2.54B
EPS	$0 ( 2024-05-01 )
Następna data zysków	( $0.220 ) 2024-05-17
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	26.09
ATR14	$0.0380 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Swisher Daniel N Jr	Sell	2 200	Stock option (right to buy)
2024-05-01	Swisher Daniel N Jr	Buy	2 200	Common Stock
2024-05-01	Swisher Daniel N Jr	Sell	2 200	Common Stock
2024-04-10	Mahoney David L	Buy	27 806	Common Stock
2024-04-10	Mahoney David L	Buy	30 000	Common Stock

INSIDER POWER
61.98
Last 97 transactions
Buy: 1 926 069 \| Sell: 453 397

Wolumen Korelacja

Długi: 0.34 (neutral)

Krótki: 0.98 (very strong)

Signal:(60.992) Expect same movement, but be aware

Corcept Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
GOODM	0.945
SVAC	0.941
PAIC	0.916
TLGT	0.913
ALVR	0.898
GETVV	0.897
RMRM	0.897
SVOK	0.891
BNDX	0.889
MTSL	0.888

10 Najbardziej negatywne korelacje
AMRB	-0.968
NETE	-0.941
MMAC	-0.919
PFG	-0.901
LINC	-0.887
FFBW	-0.872
SRAC	-0.871
REG	-0.865
IOSP	-0.865
NOVT	-0.861

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Corcept Therapeutics Inc Korelacja - Waluta/Towar

-0.71
( moderate negative )

-0.73
( moderate negative )

0.00
( neutral )

-0.80
( strong negative )

0.82
( strong )

Corcept Therapeutics Inc Finanse

Annual	2023
Przychody:	$482.38M
Zysk brutto:	$475.89M (98.66 %)
EPS:	$1.020

FY	2023
Przychody:	$482.38M
Zysk brutto:	$475.89M (98.66 %)
EPS:	$1.020

FY	2022
Przychody:	$401.86M
Zysk brutto:	$396.47M (98.66 %)
EPS:	$0.950

FY	2021
Przychody:	$365.98M
Zysk brutto:	$360.70M (98.56 %)
EPS:	$0.970

Financial Reports:

No articles found.

Corcept Therapeutics Inc

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.